Informations sur le produit
LDN-209929 is a synthetic peptide that has been shown to inhibit the activity of protein kinase C (PKC). It was originally developed as a research tool for studying PKC, but it has also been shown to have potential as a drug candidate for the treatment of cancer. LDN-209929 is an inhibitor of PKC and can be used in experiments to study PKC's role in various cellular processes, such as cell proliferation, apoptosis, and signal transduction. The peptide binds to PKC and prevents the activation of PKC by other molecules. LDN-209929 may also be used as an antibody or receptor ligand.
LDN-209929 is a high purity compound that can be used in life science research. LDN-209929 has CAS number 1784281-97-5.